Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Tirzepatide Dosage Chart 2026: Mounjaro & Zepbound Titration
guidesComplete tirzepatide dosage chart showing Mounjaro and Zepbound titration protocols week-by-week from 2.5mg to 15mg. Includes what to expect at each dose level, side effects by tier, printable download, and a free dosing calculator.
Retatrutide Dosage Chart: 2mg to 12mg Week-by-Week Schedule
guidesComplete GLP-3 retatrutide dosage chart showing the Phase 2/3 clinical trial titration from 2mg to 12mg weekly. Includes what to expect at each dose, weight loss results by tier, side effects data, printable download, and free dosing calculator.
Semaglutide Dosage Chart: Ozempic vs Wegovy Titration Schedule (2026)
guidesComplete semaglutide dosage chart showing Ozempic (1.0 mg max) and Wegovy (2.4 mg maintenance, 7.2 mg max) titration protocols week-by-week. Includes what to expect at each dose level, side effects data, printable download, and a free dosing calculator.